Finding clinical trials

Clinical trials status: Active

Enrollment status: Pre-screening

Phase: № I

BCD-236-1

Ovarian cancer, Kidney cancer

Clinical trials status: Active

Enrollment status: Open

Phase: № II

BCD-248-2/FLAMMINGO

Multiple Myeloma

Clinical trials status: Active

Enrollment status: Pre-screening

Phase: № III

ANB-002-2/MAGNOLIA

Hemophilia B

Clinical trials status: Active

Enrollment status: Pre-screening

Phase: № I

BCD-281-1

Multiple Sclerosis

Clinical trials status: Active

Enrollment status: Pre-screening

Phase: № III

BCD-085-16/PLANETA-KIDS

Plaque Psoriasis

Clinical trials status: Active

Enrollment status: Open

Phase: № II

BCD-236-2/AREAL

Breast Cancer

Clinical trials status: Active

Enrollment status: Pre-screening

Phase: № I

BCD-261-1

None

Clinical trials status: Active

Enrollment status: Conducted

18+

Phase: № III

BCD-263-2/UNIVERSE

Melanoma

Clinical trials status: Active

Enrollment status: Open

0+

Phase: № I–II

ANB-004-1/BLUEBELL

Spinal Muscular Atrophy

Clinical trials status: Conducted

Enrollment status: Open

14+

Phase: № III

BCD-132-5/LIBERIUS

Systemic Sclerosis (Scleroderma)

Clinical trials status: Active

Enrollment status: Conducted

Phase: № III

BCD-132-6/AQUARELLE

Devic’s Disease, Opticomyelitis

Clinical trials status: Conducted

Enrollment status: Pre-screening

Phase: № I

BCD-248-1

Multiple Myeloma

Clinical trials status: Active

Enrollment status: Open

Phase: № I–II

ANB-002-1/SAFRAN

Hemophilia B

Clinical trials status: Active

Enrollment status: Open

Phase: № III

BCD-217-3/NEO-MIMAJOR

Melanoma

Clinical trials status: Active

Enrollment status: Pre-screening

Phase: № I–II

ANB-010-1/EDELWEISS

Hemophilia A

Clinical trials status: Active

Enrollment status: Conducted

18+

Phase: № I

BCD-245-1

Neuroblastoma, Osteosarcoma, Ewing’s Sarcoma, Rhabdomyosarcoma, Undifferentiated Soft Tissue Sarcoma

Clinical trials status: Active

Enrollment status: Conducted

1+

Phase: № II–III

BCD-245-2/WINNER

Neuroblastoma

Clinical trials status: Active

Enrollment status: Conducted

Phase: № III

BCD-264-2/DARVIVA

Multiple Myeloma

Clinical trials status:

Enrollment status: Conducted

Phase: № III

BCD-180-3/LEVENTA

Axial Spondyloarthritis, Bechterew’s disease

Clinical trials status: Active

Enrollment status: Conducted

Phase: № I

BCD-236-1

Melanoma, Breast Cancer, Ovarian Cancer, Kidney Cancer, Malignant Neoplasms

Clinical trials status: Active

Enrollment status: Conducted

Phase: № III

BCD-089-5/LUNAR

Rheumatoid Arthritis

Clinical trials status: Active

Enrollment status: Conducted

Phase: № I–II

BCD-106-1

Solid Tumors

Clinical trials status: Active

Enrollment status: Conducted

Phase: № I

BCD-263-1

Melanoma

Clinical trials status: Conducted

Enrollment status: Conducted

Phase: № I

BCD-253-1

None

Clinical trials status: Active

Enrollment status: Conducted

Phase: № III

BCD-178-2/PREFER

Breast Cancer

Clinical trials status: Active

Enrollment status: Conducted

Phase: № III

BCD-217-2/OCTAVA

Melanoma

Clinical trials status: Active

Enrollment status: Conducted

Phase: № III

BCD-201-2

Melanoma

Clinical trials status: Active

Enrollment status: Conducted

Phase: № I

BCD-178-1

None

Clinical trials status: Active

Enrollment status: Conducted

Phase: № III

BCD-100-5/FERMATA

Cervical Cancer

Clinical trials status: Active

Enrollment status: Conducted

Phase: № III

BCD-100-3/DOMAJOR

Non-Small Cell Lung Cancer

Clinical trials status: Active

Enrollment status: Conducted

Phase: № II

BCD-180-2/ELEFTA

Axial Spondyloarthritis, Bechterew’s disease

Clinical trials status: Conducted

Enrollment status: Conducted

Phase: № III

BCD-132-4/MIRANTIBUS

Multiple Sclerosis

Clinical trials status: Conducted

Enrollment status: Conducted

Phase: № III

BCD-100-8/FLAT

Melanoma